neurology
Pain

No clear winners but two drugs stand out for idiopathic neuropathic pain

Nortriptyline and duloxetine are the best, but not great options for managing patients with cryptogenic sensory polyneuropathy (CSPN). A US study of 402 patients from 40 clinical sites comparing nortriptyline, duloxetine, pregabalin and mexiletine found there was a need for new, more effective drugs for idiopathic neuropathic pain. The PAIN-CONTRoLS study, published in JAMA Neurology, ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic